1.
LuanPV, TienND, HaiNM, TienND, DuyenTT. Real-world analysis of the effect of gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer with EGFR mutations. YDLS [Internet]. 1 Tháng Tư 2021 [cited 28 Tháng Giêng 2022];15(Tiếng Anh). Available at: https://tcydls108.benhvien108.vn/index.php/YDLS/article/view/733